about
Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic reviewIncreased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activityCrystal Structure of Bacillus anthracis Dihydrofolate Reductase with the Dihydrophthalazine-Based Trimethoprim Derivative RAB1 Provides a Structural Explanation of Potency and SelectivityTransient erythroid hypoplasia in a patient on long-term co-trimoxazole therapyToxicity of co-trimoxazole in nutritional haematinic deficiencyResistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.A haematological study of patients receiving long-term treatment with trimethoprim and sulphonamideEvolution of antibiotic resistance gene functionSingle-dose treatment of gonorrhoea with cotrimoxazole. A report on 1,223 cases.Inhibition of Neisseria gonorrhoeae isolates by Martin-Lewis medium. Epidemiology, susceptibility profile, and plasma analysis.Use of trimethoprim to prevent overgrowth by Proteus in the cultivation of N. gonorrhoeae.Diagnosis of gonorrhoea by culture on a selective medium containing vancomycin, colistin, nystatin and trimethoprim (VCNT). A comparison with Gram-staining and immunofluorescenceSynergy of trimethoprim-sulfamethoxazoleComparison of in vitro susceptibility of Neisseria gonorrhoeae to trimethoprim-sulfamethoxazole on three different media.Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora.Minimal inhibitory concentrations of 19 antimicrobial agents for 96 clinical isolates of group IVe bacteria.The combination of trimethoprim and sulfamethoxazole in the treatment of urinary tract infection.Trimethoprim-sulfamethoxazole compared with sulfamethoxazole in urinary tract infection.The use of trimethoprim-sulfamethoxazole in gonococcal infections.A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneysTrimethoprim and co-trimoxazole in the treatment of acute urinary tract infections: patient compliance and efficacySulphadimidine, co-trimoxazole, and a placebo in the management of symptomatic urinary tract infection in general practice.Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testingSensitivity of Nocardia to trimethoprim and sulphonamides in vitroSulphamethoxazole-trimethoprim: the first two yearsThe sensitivity of Pseudomonas pseudomallei to trimethoprim and sulphamethoxazole in vitroComparative, double-blind, prospective, multicenter trial of temafloxacin versus trimethoprim-sulfamethoxazole in uncomplicated urinary tract infections in women.Esch. coli endocarditis successfully treated with oral trimethoprim and sulphamethoxazole.Evaluation of antibiotic susceptibility testing by agar dilution and the Micro Media system (Fox Panel)Utility of the Biosynthetic Folate Pathway for Targets in Antimicrobial Discovery.Treatment of gonorrhoea with trimethoprim-sulphamethoxazole in Uganda.Deletion of nudB Causes Increased Susceptibility to Antifolates in Escherichia coli and Salmonella enterica.Synergism between chlorhexidine and sulphadiazine.Correlation of trimethoprim and brodimoprim physicochemical and lipid membrane interaction properties with their accumulation in human neutrophils.Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases.Co-trimoxazole susceptibility tests improved with separate trimethoprim and sulfamethoxazole disks.Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared mediaModification of the microtiter technique for antimicrobial drug susceptibility testing by incorporation of indicators.
P2860
Q21133667-3B654F6F-B2AF-450B-BD61-E1F89DB153DEQ27653751-D1D9FC57-62DD-41FD-BDCA-79B99B794419Q27654731-EF442BBB-A3C3-4CCD-ADE5-FFB68350D817Q28363383-4EB5A406-9D3B-441C-9274-6379CC8B2172Q28364106-512C2208-8212-4AE5-ACE6-D85107530179Q30451395-B1ED5D91-3719-4478-9985-2035D9A0B482Q33467573-E3509699-28CF-440B-B687-7A9171859A9AQ33625214-214FF429-0CDC-4310-85E8-C12E646D9755Q33654772-F93E1531-7F85-40A2-8854-D8E1A81A1071Q33658671-00811CBA-A749-4927-8256-AB6D1A4319A9Q33665650-EC2D975C-44B1-4D3B-A112-EA78DB5B16EAQ33666838-E7924350-EBA8-4340-8C33-B24858F09727Q33998386-9A8F2ACD-AC22-4429-B154-F020EB89E345Q34953777-66A22B33-7696-41D5-A43C-5D2FC20263F5Q35669909-6E6C2C09-768C-492A-B2FD-1D2864C25A1EQ35754454-3E72FFF1-DF50-4A71-A21C-6EC7765EF72FQ35926543-D95AC72D-63F2-4ADB-AA0B-24E18AD0A162Q35938601-815B3643-C40D-432C-B3F6-B7C73577F376Q35958700-4876D68E-E74A-4A39-8BF9-B6603D104800Q35958741-773D8D45-C063-4FAB-9DEF-2BFA090D1F54Q35980691-A505B029-2DF9-4CA7-A45B-829AC5065FA4Q36302756-B42AB88E-5929-40C4-ABDA-A5865EDA1E28Q36414013-4EEC7A56-AC16-4CBC-A1BC-1F5926C4F821Q36473752-AB401B0F-1DA5-46B7-B6AA-0CDCE7BEC2A2Q36620455-28FE8D87-ABDF-4FCF-B7C5-5559FFA3DD1EQ36627889-F34AFD2E-84AA-4A4F-A587-F255F96724EDQ36632778-DC55182F-1FCC-42ED-AB9C-1785D94CB89EQ36754805-67511B73-DFB3-4D3A-AAB8-FE27BDFAE8BAQ36916677-42EFF965-E786-4304-9A62-1B91B516A81CQ37197293-43CFCE77-B44E-4E7B-AC9C-CEBD5529E7A5Q38792855-92DB77E3-9C36-40BC-8471-718838AB3A12Q38896285-EDC6556D-189B-4B5A-9104-BA153C8A5CEDQ38949292-AFAA5663-2CF9-44F5-AD48-4B511497A580Q39639919-97E3693C-41CE-40EA-BA88-77CA1599C984Q39783334-01B811B4-7416-4602-B432-6EE1CB9257F7Q39856512-FF659D48-6F32-49E6-AB85-582F837CAD12Q40214688-8B87FF97-38C2-4E52-89AA-9283A5FB557AQ40232288-8D61DB25-4A09-4711-9E5E-F56EF18CE006Q40711327-522B704F-A695-42C8-B159-4E6ACA1F25A9Q40713933-D8EE1C41-71ED-44B3-8CBF-3651B0A2A830
P2860
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年論文
@yue
1968年論文
@zh-hant
1968年論文
@zh-hk
1968年論文
@zh-mo
1968年論文
@zh-tw
1968年论文
@wuu
1968年论文
@zh
1968年论文
@zh-cn
name
Trimethoprim: laboratory and clinical studies.
@ast
Trimethoprim: laboratory and clinical studies.
@en
type
label
Trimethoprim: laboratory and clinical studies.
@ast
Trimethoprim: laboratory and clinical studies.
@en
prefLabel
Trimethoprim: laboratory and clinical studies.
@ast
Trimethoprim: laboratory and clinical studies.
@en
P2093
P356
P1476
Trimethoprim: laboratory and clinical studies.
@en
P2093
Darrell JH
Waterworth PM
P2860
P304
P356
10.1136/JCP.21.2.202
P407
P577
1968-03-01T00:00:00Z